AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directions

Autor: Karl B. Fields, Chad A. Asplund, Kimberly G. Harmon, Francis G. O'Connor, Robert J. Dimeff, David E. Price, Irfan M. Asif, William O. Roberts, Jonathan A. Drezner, David T. Bernhardt
Rok vydání: 2016
Předmět:
Health Knowledge
Attitudes
Practice

medicine.medical_specialty
Sports medicine
Population
Advisory Committees
MEDLINE
Alternative medicine
Eligibility Determination
Physical Therapy
Sports Therapy and Rehabilitation

Context (language use)
Physical examination
030204 cardiovascular system & hematology
Sports Medicine
Cardiovascular System
Electrocardiography
03 medical and health sciences
0302 clinical medicine
medicine
Humans
Mass Screening
Orthopedics and Sports Medicine
education
Physical Examination
Societies
Medical

education.field_of_study
medicine.diagnostic_test
biology
Athletes
business.industry
Public Health
Environmental and Occupational Health

Sudden cardiac arrest
030229 sport sciences
General Medicine
medicine.disease
biology.organism_classification
United States
Harm
Death
Sudden
Cardiac

Early Diagnosis
Cardiovascular Diseases
Family medicine
Practice Guidelines as Topic
Exercise Test
Physical therapy
Medical emergency
medicine.symptom
business
Sports
Zdroj: British journal of sports medicine. 51(3)
ISSN: 1473-0480
Popis: Cardiovascular screening in young athletes is widely recommended and routinely performed prior to participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for cardiovascular screening in athletes remains an issue of considerable debate. At the center of the controversy is the addition of a resting electrocardiogram (ECG) to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation cardiovascular screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcomes-based evidence at this time precludes AMSSM from endorsing any single or universal cardiovascular screening strategy for all athletes, including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate cardiovascular screening strategy unique to their athlete population, community needs, and resources. The decision to implement a cardiovascular screening program, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence-base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. AMSSM is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.
Databáze: OpenAIRE